These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 3598594)

  • 1. Isolation, structure, and synthesis of combretastatins A-1 and B-1, potent new inhibitors of microtubule assembly, derived from Combretum caffrum.
    Pettit GR; Singh SB; Niven ML; Hamel E; Schmidt JM
    J Nat Prod; 1987; 50(1):119-31. PubMed ID: 3598594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation, structure, synthesis, and antimitotic properties of combretastatins B-3 and B-4 from Combretum caffrum.
    Pettit GR; Singh SB; Schmidt JM; Niven ML; Hamel E; Lin CM
    J Nat Prod; 1988; 51(3):517-27. PubMed ID: 3404149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a).
    Pettit GR; Singh SB; Boyd MR; Hamel E; Pettit RK; Schmidt JM; Hogan F
    J Med Chem; 1995 May; 38(10):1666-72. PubMed ID: 7752190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.
    Pettit GR; Singh SB; Hamel E; Lin CM; Alberts DS; Garcia-Kendall D
    Experientia; 1989 Feb; 45(2):209-11. PubMed ID: 2920809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study.
    Lin CM; Singh SB; Chu PS; Dempcy RO; Schmidt JM; Pettit GR; Hamel E
    Mol Pharmacol; 1988 Aug; 34(2):200-8. PubMed ID: 3412321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin.
    Lin CM; Ho HH; Pettit GR; Hamel E
    Biochemistry; 1989 Aug; 28(17):6984-91. PubMed ID: 2819042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of combretastatins as potent tubulin polymerization inhibitors.
    Bukhari SNA; Kumar GB; Revankar HM; Qin HL
    Bioorg Chem; 2017 Jun; 72():130-147. PubMed ID: 28460355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplastic agents, 122. Constituents of Combretum caffrum.
    Pettit GR; Cragg GM; Singh SB
    J Nat Prod; 1987; 50(3):386-91. PubMed ID: 3668557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combretastatins: from natural products to drug discovery.
    Cirla A; Mann J
    Nat Prod Rep; 2003 Dec; 20(6):558-64. PubMed ID: 14700199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic agents. 379. Synthesis of phenstatin phosphate.
    Pettit GR; Toki B; Herald DL; Verdier-Pinard P; Boyd MR; Hamel E; Pettit RK
    J Med Chem; 1998 May; 41(10):1688-95. PubMed ID: 9572894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combretastatin A-4 analogues as antimitotic antitumor agents.
    Nam NH
    Curr Med Chem; 2003 Sep; 10(17):1697-722. PubMed ID: 12871118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Natural organic compounds that affect to microtubule functions: syntheses and structure-activity relationships of combretastatins, curacin A and their analogs as the colchicine-site ligands on tubulin].
    Iwasaki S; Shirai R
    Yakugaku Zasshi; 2000 Oct; 120(10):875-89. PubMed ID: 11082700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor and anti-vascular effects of the novel tubulin-binding agent combretastatin A-1 phosphate.
    Holwell SE; Cooper PA; Thompson MJ; Pettit GR; Lippert LW; Martin SW; Bibby MC
    Anticancer Res; 2002; 22(6C):3933-40. PubMed ID: 12553015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimitotic activity of diaryl compounds with structural features resembling combretastatin A-4.
    Aleksandrzak K; McGown AT; Hadfield JA
    Anticancer Drugs; 1998 Jul; 9(6):545-50. PubMed ID: 9877243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of the antineoplastic activity of combretastatin A-4, a natural product from Combretum caffrum (arid shrub).
    el-Zayat AA; Degen D; Drabek S; Clark GM; Pettit GR; Von Hoff DD
    Anticancer Drugs; 1993 Feb; 4(1):19-25. PubMed ID: 8457709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and biochemical comparison of the anti-mitotic agents colchicine, combretastatin A4 and amphethinile.
    McGown AT; Fox BW
    Anticancer Drug Des; 1989 Mar; 3(4):249-54. PubMed ID: 2930627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combretastatin-based compounds with therapeutic characteristics: a patent review.
    Nainwal LM; Alam MM; Shaquiquzzaman M; Marella A; Kamal A
    Expert Opin Ther Pat; 2019 Sep; 29(9):703-731. PubMed ID: 31369715
    [No Abstract]   [Full Text] [Related]  

  • 18. Combretastatins: An Overview of Structure, Probable Mechanisms of Action and Potential Applications.
    Karatoprak GŞ; Küpeli Akkol E; Genç Y; Bardakci H; Yücel Ç; Sobarzo-Sánchez E
    Molecules; 2020 May; 25(11):. PubMed ID: 32486408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineoplastic agents, 120. Pancratium littorale.
    Pettit GR; Gaddamidi V; Herald DL; Singh SB; Cragg GM; Schmidt JM; Boettner FE; Williams M; Sagawa Y
    J Nat Prod; 1986; 49(6):995-1002. PubMed ID: 3572427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineoplastic agents 442. Synthesis and biological activities of dioxostatin.
    Pettit GR; Lippert JW; Boyd MR; Verdier-Pinard P; Hamel E
    Anticancer Drug Des; 2000 Oct; 15(5):361-71. PubMed ID: 11354312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.